Oncology focuses on the diagnosis, treatment, and management of cancer and related conditions. Our specialists provide personalized, comprehensive care using advanced approaches to support each patient throughout their treatment journey.
Consultant Medical Oncologist and Clinical Hematologist
Dr. Ali Chamseddine is a French Board–Certified Consultant Medical Oncologist and Clinical Hematologist with over 15 years of experience in comprehensive cancer care and international training in France and the United States. He holds a PhD in Public Health and Molecular Oncology from the University of Paris-Saclay (summa cum laude) and has made significant contributions to clinical research, including novel methodologies in advanced gastric cancer and over 45 peer-reviewed publications, including in The New England Journal of Medicine. He trained at leading institutions such as Gustave Roussy Cancer Center and MD Anderson Cancer Center, and has held senior consultant and leadership roles in major oncology centers across France and the UAE. In Dubai, he was the founding Head of Oncology at Dr. Sulaiman Al Habib Hospital and currently practices at Al Zahra Hospital Dubai, delivering state-of-the-art, multidisciplinary cancer care. Dr. Chamseddine specializes in precision oncology, treating a broad spectrum of solid tumors and hematologic malignancies, with particular expertise in gastrointestinal, breast, lung, genitourinary, gynecologic cancers, lymphomas, and multiple myeloma, integrating molecular profiling and personalized therapies into care plans. Fluent in French, English, and Arabic, he is an active member of major international oncology societies and is widely recognized for his compassionate, evidence-based, and individualized approach to cancer treatment.
Consultant Clinical Hematology & Consultant Medical Oncology
Dr. Mohammed Allow is a Consultant Hematologist and Medical Oncologist in Abu Dhabi with over 12 years of clinical experience in the diagnosis and treatment of complex blood disorders and cancers. He earned his medical degree from Jordan University of Science and Technology and completed advanced training in Adult Hematology, Oncology, and Internal Medicine at leading hospitals in Germany. Following his training, he served as a consultant at a major hospital in Germany before continuing his practice in the UAE.
Dr. Allow’s areas of expertise include adult hematology, medical oncology, hemostaseology, and autologous stem cell transplantation. He provides comprehensive oncological care encompassing diagnosis, treatment, post‑therapy follow‑up, and long‑term patient management. He also offers specialized follow‑up care for patients undergoing allogeneic stem cell transplantation in close collaboration with international transplant centers.
Consultant Oncoplastic & Reconstructive Breast & General Surgeon
Dr. Mahmoud Abu Dakka, MBBcH, FRCS (Eng), is a UK board-certified Consultant Oncoplastic, Reconstructive Breast, and General Surgeon practicing in Dubai, with a strong focus on achieving optimal oncological and aesthetic outcomes in breast cancer surgery. He completed all his surgical training in the United Kingdom, followed by the prestigious international Querci Della Rovere Fellowship in oncoplastic and reconstructive breast surgery at Cambridge University Hospitals, The Royal Marsden Hospital in London, and Memorial Sloan Kettering Cancer Center in New York.
Dr. Abu Dakka has held senior consultant roles across the UK, Jordan, and Qatar, including serving as Breast Cancer and Clinical Governance Lead at Sherwood Forest NHS Hospitals and Director of Farah Breast Care Centre in Amman. His expertise spans oncoplastic and reconstructive breast surgery, standard and prophylactic breast cancer surgery, nipple–areola reconstruction, and cosmetic breast procedures. He is also experienced in managing benign breast conditions, male breast disease, mastalgia, lipomodelling, and rapid-access breast diagnostics. Dr. Abu Dakka is highly regarded in Dubai for providing comprehensive, patient-centred breast care, including expert second opinions.
Consultant Clinical Hematologist
Dr. Fatin Sammour is a Staff Physician in the Hematology & Blood Cancer Department at Cleveland Clinic Abu Dhabi’s Cancer Institute, with extensive clinical and academic experience from the UK and UAE. She previously served as a consultant hematologist at Prime Hospital in Dubai and at Epsom and St. Helier University Hospitals NHS Trust in the UK, where she also led the blood transfusion service. Dr. Sammour completed her specialist hematology training through the UK’s national program, with key appointments at the Royal Marsden Hospital and St. George’s Hospital, contributing to multiple clinical trials in leukemia, lymphoma, and myeloma. She earned her medical degree from the University of Southampton and a master’s in Medical Ethics and Law from King’s College London. She is a Member of the Royal College of Physicians (MRCP), a Fellow of the Royal College of Pathologists (FRCPath), and holds a Certificate of Completion of Training (CCT) in hematology. Dr. Sammour specializes in anemia, thrombocytopenia, leukopenia, portal thrombosis, leukemia, lymphoma, myeloma, myeloproliferative disorders, bleeding disorders, and obstetric hematology.
Consultant Medical Oncologist
Dr. Maher Hadaki is a UK-trained Consultant Medical Oncologist at Mediclinic Comprehensive Cancer Centre in Abu Dhabi, with over 10 years of experience as a consultant in the UK. He completed his oncology training at University College Hospital, London, and Addenbrooke’s Teaching Hospital, Cambridge, and is a fellow of the Royal College of Radiologists and a member of the Royal College of Physicians. Dr. Hadaki specializes in the use of radiotherapy for early and advanced cancers, with a particular interest in stereotactic ablative radiotherapy (SABR) and advanced targeted therapies.
He treats all stages of breast cancer and manages a wide range of malignancies, combining chemotherapy, immunotherapy, radiotherapy, biological therapies, and molecular-guided treatments for personalized care. He participates in multidisciplinary team meetings and has access to clinical trials, local ablative therapies, and palliative care services to provide comprehensive cancer management. Dr. Hadaki collaborates with leading surgeons and integrates state-of-the-art technologies, including IMRT, IGRT, and Cyberknife, into his treatment plans.
He is registered with major private medical insurers, including BUPA, AXA, Aviva, and Vitality, and treats both local and international patients. Dr. Hadaki’s practice emphasizes evidence-based, individualized oncology care, combining advanced treatments with holistic patient support.
Abu Dhabi Stem Cells Center (ADSCC) is a specialized healthcare and research institution focused on regenerative medicine, cell therapy, and advanced biomedical research. Based in Abu Dhabi, the center combines scientific innovation with clinical expertise to deliver safe, evidence-based treatments aligned with international medical standards.
Through state-of-the-art facilities and a multidisciplinary team of clinicians and researchers, ADSCC supports the development, processing, and clinical application of stem cell therapies. The center is committed to advancing medical knowledge through research, collaboration, and ethical practice, contributing to the UAE’s growing leadership in advanced healthcare.
Burjeel Clinics refers to the network of primary care and outpatient medical centres in Abu Dhabi, United Arab Emirates, operated by the private healthcare group Burjeel Holdings. These clinics provide accessible, community‑focused healthcare services covering general and family medicine, internal medicine, pediatrics, women’s health, dental care, radiology, and basic diagnostics, helping patients manage preventive care, common illnesses and chronic conditions. They act as part of a wider “hub‑and‑spoke” healthcare model that connects patients needing more advanced treatment with Burjeel’s larger specialist hospitals and day‑surgery facilities.
Burjeel Hospital is a leading healthcare services provider in Abu Dhabi. The hospital delivers comprehensive, patient-focused care across multiple medical disciplines, supported by modern infrastructure and advanced medical technologies.
With a strong emphasis on clinical excellence, governance, and innovation, Burjeel Hospital brings together experienced healthcare professionals and multidisciplinary teams to provide high-quality services aligned with international standards. The organization plays a key role in strengthening Abu Dhabi’s healthcare ecosystem through continuous investment in medical capability, education, and specialized care.
Burjeel Medical City is a major quaternary‑care hospital in Mohamed Bin Zayed City, Abu Dhabi, United Arab Emirates, and one of the largest private healthcare facilities in the region. It spans over 1.2 million sq ft with more than 400 beds and offers comprehensive medical services across a wide range of specialties, including oncology, transplant medicine, neurosurgery, pediatrics, rehabilitation, and critical care.
The hospital is internationally accredited and known for advanced treatments, such as its Integrated Oncology & Palliative Care Centre accredited by the European Society for Medical Oncology (ESMO), 24/7 emergency services with a helipad, and state‑of‑the‑art diagnostic and surgical technologies. BMC combines world‑class clinical expertise with patient‑centered care for both local residents and international patients.
Cleveland Clinic is a healthcare facility providing comprehensive, specialized medical and surgical services supported by multidisciplinary clinical teams. The facility delivers inpatient, outpatient, emergency, and diagnostic care using modern clinical infrastructure and advanced medical technologies.
With an emphasis on patient safety, quality, and evidence-based treatment, Cleveland Clinic operates within standardized clinical governance frameworks. The facility plays an important role in delivering reliable, high-quality care aligned with national and international healthcare standards.
Mediclinic Airport Road Hospital is a multi-specialty hospital in Abu Dhabi providing comprehensive medical and surgical services across a wide range of clinical disciplines. The hospital is equipped with advanced diagnostic and treatment technologies and focuses on delivering high-quality, patient-centered care.
As part of the Mediclinic International network, the hospital emphasizes clinical excellence, safety, and evidence-based practice. Its experienced medical teams work collaboratively to deliver care aligned with international healthcare standards, supporting Abu Dhabi’s growing healthcare infrastructure.
NMC Royal Hospital is a multi-specialty hospital in Abu Dhabi providing a wide range of medical and surgical services. The hospital is equipped with advanced diagnostic and treatment technologies and is designed to deliver comprehensive, patient-focused care.
Supported by experienced physicians and multidisciplinary healthcare teams, the hospital emphasizes clinical quality, safety, and evidence-based practice. NMC Royal Hospital contributes to Abu Dhabi’s healthcare network by delivering services aligned with international medical standards.
Sheikh Khalifa Medical City (SKMC) is a major tertiary hospital in Abu Dhabi and part of the SEHA healthcare network. The facility provides comprehensive acute, specialty, and critical care services, supported by advanced diagnostic and treatment capabilities.
With a strong focus on clinical excellence, patient safety, and multidisciplinary care, SKMC delivers evidence-based services aligned with international healthcare standards. The hospital plays a vital role within Abu Dhabi’s public healthcare system, supporting complex care delivery, medical education, and continuous improvement in patient outcomes.
Sheikh Shakhbout Medical City (SSMC) is a leading tertiary care hospital in Abu Dhabi providing advanced, complex, and critical care services across a wide range of medical specialties. The hospital is equipped with state-of-the-art diagnostic and treatment technologies and is designed to support high-acuity patient care.
As part of Abu Dhabi’s public healthcare system, SSMC emphasizes clinical excellence, patient safety, and multidisciplinary collaboration. Supported by highly specialized medical teams, the hospital delivers evidence-based care aligned with international standards and plays a key role in medical education, research, and trauma care within the emirate.
Burjeel Hospital, Al Ain (often referred to as Burjeel Royal Hospital, Al Ain) is a multi‑specialty private hospital part of the Burjeel Holdings healthcare network, serving the Al Ain community in the UAE with comprehensive medical and surgical care. It provides a wide range of services across specialties including general medicine, surgery, pediatrics, obstetrics & gynecology, urology, pulmonology, dermatology and more, supported by modern diagnostic and treatment facilities.
The hospital operates with a 24/7 emergency department staffed by experienced clinicians to handle urgent medical and surgical cases, and is equipped with advanced technology to deliver high‑quality, patient‑centered care.
In addition to core clinical services, the Burjeel network in Al Ain includes specialty services such as a dedicated oncology centre offering comprehensive cancer diagnostics and treatments, reinforcing the hospital’s commitment to accessible and world‑class healthcare for the region.
NMC Specialty Hospital, Al Ain is a well‑established multi‑specialty private hospital in Al Ain, UAE, and part of the NMC Healthcare network, one of the UAE’s largest private healthcare providers.
The hospital was established in 2007 and offers comprehensive medical care across a broad range of specialties including internal medicine, surgery, pediatrics, obstetrics & gynecology, orthopedics, cardiology, gastroenterology, urology and more, supported by modern diagnostic and therapeutic technology.
Equipped with advanced imaging and laboratory facilities, a 24/7 emergency department, inpatient beds and experienced clinical teams, NMC Specialty Hospital serves both Al Ain residents and patients from surrounding areas with patient‑centred, quality healthcare.
Sheikh Tahnoun Bin Mohammed Medical City (STMC), Al Ain is a major tertiary medical hub in Al Ain, Abu Dhabi, UAE, operated under the SEHA (Abu Dhabi Health Services Company) network. It is one of the region’s most advanced healthcare facilities, designed around a “Healing Oasis” concept to promote comfort and recovery within a modern, patient‑centred environment. STMC features a large capacity of around 700+ beds and offers a wide range of specialized services including trauma care, orthopedics, cardiology, neurology, surgical oncology, emergency medicine and comprehensive rehabilitation programmes. It also includes dedicated centres of excellence such as the UAE’s first stroke unit and a standalone rehabilitation centre, and serves as a teaching and research hospital affiliated with United Arab Emirates University, integrating clinical care with education and innovation.
Tawam Hospital is a major tertiary care hospital in Al Ain, Abu Dhabi, and part of the SEHA healthcare network. The hospital provides comprehensive medical, surgical, and specialty services, with a strong focus on complex and advanced care supported by modern diagnostic and treatment technologies.
Renowned for its expertise in oncology and specialized services, Tawam Hospital emphasizes clinical excellence, patient safety, and multidisciplinary collaboration. The hospital delivers evidence-based care aligned with international standards and plays a key role in supporting advanced healthcare delivery, education, and research within Abu Dhabi’s public health system.
Al Garhoud Hospital is a healthcare facility in Dubai providing a range of medical and surgical services across key clinical specialties. The hospital supports inpatient and outpatient care through modern facilities, diagnostic capabilities, and patient-focused service delivery.
With an emphasis on clinical quality, safety, and evidence-based practice, Al Garhoud Hospital is supported by experienced healthcare professionals and multidisciplinary teams. The hospital contributes to Dubai’s healthcare system by delivering services aligned with international standards and regulatory requirements.
Al Jalila Children’s Hospital is a dedicated pediatric hospital in Dubai providing specialized medical and surgical care for infants, children, and adolescents. The hospital offers a comprehensive range of pediatric services supported by advanced diagnostic technologies and child-focused clinical environments.
As part of Dubai’s public healthcare system, the hospital emphasizes clinical excellence, patient safety, and family-centered care. Supported by specialized pediatric teams, Al Jalila Children’s Hospital delivers evidence-based services aligned with international pediatric healthcare standards and plays a key role in advancing children’s health in the emirate.
